Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome after T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant Cyclophosphamide.

MLA

Willem, Catherine, et al. “Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome after T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant Cyclophosphamide.” Journal of Immunology (Baltimore, Md. : 1950), vol. 202, no. 7, Apr. 2019, pp. 2141–52. EBSCOhost, https://doi.org/10.4049/jimmunol.1801489.

APA

Willem, C., Makanga, D. R., Guillaume, T., Maniangou, B., Legrand, N., Gagne, K., Peterlin, P., Garnier, A., Béné, M. C., Cesbron, A., Le Bourgeois, A., Chevallier, P., & Retière, C. (2019). Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome after T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant Cyclophosphamide. Journal of Immunology (Baltimore, Md. : 1950), 202(7), 2141–2152. https://doi.org/10.4049/jimmunol.1801489

Chicago

Willem, Catherine, Dhon Roméo Makanga, Thierry Guillaume, Bercelin Maniangou, Nolwenn Legrand, Katia Gagne, Pierre Peterlin, et al. 2019. “Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome after T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant Cyclophosphamide.” Journal of Immunology (Baltimore, Md. : 1950) 202 (7): 2141–52. doi:10.4049/jimmunol.1801489.